tradingkey.logo

Autonomix Medical Inc

AMIX
0.398USD
+0.045+12.67%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
2.47MMarktkapitalisierung
VerlustKGV TTM

Autonomix Medical Inc

0.398
+0.045+12.67%

mehr Informationen über Autonomix Medical Inc Unternehmen

Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.

Autonomix Medical Inc Informationen

BörsenkürzelAMIX
Name des UnternehmensAutonomix Medical Inc
IPO-datumJan 29, 2024
CEOHauser (Bradley)
Anzahl der mitarbeiter8
WertpapierartOrdinary Share
GeschäftsjahresendeJan 29
Addresse21 Waterway Ave, Suite 300
StadtTHE WOODLANDS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl77380
Telefon18322777816
Websitehttps://autonomix.com/
BörsenkürzelAMIX
IPO-datumJan 29, 2024
CEOHauser (Bradley)

Führungskräfte von Autonomix Medical Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
10.98K
+10982.00%
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Jonathan P. Foster
Mr. Jonathan P. Foster
Independent Director
Independent Director
--
--
Ms. Lori H. Bisson
Ms. Lori H. Bisson
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
--
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
--
--
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
10.98K
+10982.00%
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Wed, Jan 28
Aktualisiert: Wed, Jan 28
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Klemp (Walter V.)
2.18%
BioStar Ventures III, L.P.
1.75%
Heights Capital Management, Inc.
1.68%
Toth (Landy)
1.47%
Mariner Wealth Advisors
1.46%
Andere
91.46%
Aktionäre
Aktionäre
Anteil
Klemp (Walter V.)
2.18%
BioStar Ventures III, L.P.
1.75%
Heights Capital Management, Inc.
1.68%
Toth (Landy)
1.47%
Mariner Wealth Advisors
1.46%
Andere
91.46%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
4.96%
Investment Advisor
3.53%
Corporation
1.75%
Hedge Fund
0.89%
Venture Capital
0.20%
Investment Advisor/Hedge Fund
0.15%
Andere
88.52%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
39
329.96K
7.13%
--
2025Q3
39
329.96K
7.93%
+35.06K
2025Q2
35
294.92K
16.34%
-135.37K
2025Q1
30
430.29K
14.58%
+71.16K
2024Q4
29
489.76K
8.72%
+336.46K
2024Q3
25
18.30K
0.40%
+13.75K
2024Q2
19
4.55K
0.18%
+2.81K
2024Q1
10
1.66K
0.00%
+1.66K

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Klemp (Walter V.)
150.75K
2.18%
--
--
Sep 19, 2025
BioStar Ventures III, L.P.
120.82K
1.75%
--
--
Jun 30, 2025
Heights Capital Management, Inc.
116.09K
1.68%
-18.91K
-14.01%
Dec 31, 2024
Toth (Landy)
101.31K
1.47%
--
--
Sep 19, 2025
Mariner Wealth Advisors
100.64K
1.46%
--
--
Sep 30, 2025
Foster (Jonathan P.)
36.56K
0.53%
--
--
Sep 19, 2025
Schwartz (Robert)
35.77K
0.52%
--
--
Sep 19, 2025
Two Sigma Investments, LP
25.02K
0.36%
+25.02K
--
Sep 30, 2025
BMO Nesbitt Burns Inc.
25.00K
0.36%
+25.00K
--
Sep 30, 2025
Ikarian Capital LLC
20.00K
0.29%
--
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Datum
Ex-Dividendentag
Art
Verhältnis
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
KeyAI